Abstract:Background and Objective: Non-small cell lung cancer (NSCLC) accounts for 80-85% of all patients with lung cancer and 5-year relative overall survival (OS) rate is less than 20%, so that identifying novel diagnostic and prognostic biomarkers is urgently demanded. The present study attempted to identify potential key genes associated with the pathogenesis and prognosis of NSCLC. Methods: Four GEO datasets (GSE18842, GSE19804, GSE43458, and GSE62113) were obtained from the Gene Expression Omnibus (GEO) database. The differentially expressed genes (DEGs) between NSCLC samples and normal ones were analyzed using limma package, and RobustRankAggreg (RRA) package was used to conduct gene integration. Moreover, Search Tool for the Retrieval of Interacting Genes database (STRING), Cytoscape, and Molecular Complex Detection (MCODE) were utilized to establish protein-protein interaction (PPI) network of these DEGs. Furthermore, functional enrichment and pathway enrichment analyses for DEGs were performed by Funrich and OmicShare. While the expressions and prognostic values of top genes were carried out through Gene Expression Profiling Interactive Analysis (GEPIA) and Kaplan Meier-plotter (KM) online dataset. Results: A total of 249 DEGs (113 upregulated and 136 downregulated) were identified after gene integration. Moreover, the PPI network was established with 166 nodes and 1784 protein pairs. Topoisomerase II alpha (TOP2A), a top gene and hub node with higher node degrees in module 1, was significantly enriched in mitotic cell cycle pathway. In addition, Interleukin-6 (IL-6) was enriched in amb2 integrin signaling pathway. The mitotic cell cycle was the most significant pathway in module 1 with the highest P-value. Besides, five hub genes with high degree of connectivity were selected, including TOP2A, CCNB1, CCNA2, UBE2C, and KIF20A, and they were all correlated with worse OS in NSCLC. Conclusion: The results showed that TOP2A, CCNB1, CCNA2, UBE2C, KIF20A, and IL-6 may be potential key genes, while the mitotic cell cycle pathway may be a potential pathway contribute to progression in NSCLC. Further, it could be used as a new biomarker for diagnosis and to direct the synthesis medicine of NSCLC.

Large-Scale Screening for Genes Related to Pathogenesis of Pituitary Carcinoma

Potential biomarkers and lncRNA-mRNA regulatory networks in invasive growth hormone-secreting pituitary adenomas

Study on the Gene Expression Profile and Molecular Mechanism of Pituitary Tumors

Bioinformatics Analysis of Gene Expression Profile of Serous Ovarian Carcinomas to Screen Key Genes and Pathways

Screening for Candidate Genes Related to Breast Cancer with Cdna Microarray Analysis

The Gene Expression Profiles of Pituitary Adenomas Studied by Cdna Microarray

Gene expression profiling in human null cell pituitary adenoma tissue

Large-scale cDNA transfection screening for genes related to cancer development and progression.

Single-Cell Sequencing Identifies Cellular Origins and Differentiation Markers for Molecular Classification and Recurrence Prediction of PitnNET

Identification of Novel Human Glioblastoma-Specific Transcripts by Serial Analysis of Gene Expression Data Mining

Clinicopathological analysis of densely and sparsely granulated somatotroph tumors of pituitary

Differential proteomic expression in non-functional pituitary neuroendocrine tumours and pituitary glands

Identification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics Analysis

Single-cell Transcriptome and Genome Analyses of Pituitary Neuroendocrine Tumors.

Identification of Potential Biomarkers with Diagnostic Value in Pituitary Adenomas Using Prediction Analysis for Microarrays Method

Screening the Tumor-Associated Genes by Integrate Analysis of Gene Expression Profiling of Colon Carcinoma

Screening for differential genes of the prostate cancer and bioinformatics analysis of their interaction

Isolation of Novel Differentially Expressed Genes Related to Human Glioma Using CDNA Microarray and Characterizations of Two Novel Full-length Genes

Digital Image Analysis Allows Objective Stratification of Patients with Silent PIT1-lineage Pituitary Neuroendocrine Tumors.

Comprehensive mapping of somatotroph pituitary neuroendocrine tumour heterogeneity using spatial and single‐cell transcriptomics

Identification and Analysis of Genes Associated with Papillary Thyroid Carcinoma by Bioinformatics Methods